562840-47-5

Usage

Uses

Used in Pharmaceutical Industry:
2,6-DIMETHOXYPYRIDINE-3-METHANOL is used as a building block in organic synthesis for the production of pharmaceuticals. Its unique structure and functional groups make it a valuable component in the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
2,6-DIMETHOXYPYRIDINE-3-METHANOL is used as a building block in organic synthesis for the production of agrochemicals. Its potential applications in this field can contribute to the development of new pesticides, herbicides, and other agricultural chemicals.
Used in Medicinal Chemistry and Drug Discovery:
2,6-DIMETHOXYPYRIDINE-3-METHANOL is used as a starting material or intermediate in the synthesis of various biologically active compounds. Its potential applications in medicinal chemistry and drug discovery make it a valuable tool for researchers working on the development of new therapeutic agents.
Used in Scientific Research and Development:
2,6-DIMETHOXYPYRIDINE-3-METHANOL is used in scientific research and development due to its potential biological activities. Researchers are interested in exploring its properties and applications in various fields, including drug discovery, medicinal chemistry, and agrochemical development.

InChI:InChI=1/C8H11NO3/c1-11-7-4-3-6(5-10)8(9-7)12-2/h3-4,10H,5H2,1-2H3

Upstream product

• 58819-72-0 2,6-dimethoxypyridine-3-carboxaldehyde 
• 13445-16-4 3-bromo-2,6-dimethoxypyridine 
• 6231-18-1 2,6-dimethoxypyridine 
• 562840-46-4 2,6-dimethoxynicotinic acid ethyl ester 
• 50-00-0 formaldehyd 
• 1188303-83-4 3-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-2,6-dimethoxypyridine 
• 221006-70-8 2,6-dimethoxypyridine-3-boronic acid 

Downstream Products

• 934286-66-5 C₈H₁₀NO₂Br 
• 65515-26-6 methyl 2,6-dimethoxypyridine-3-carboxylate 
• 934286-83-6 C₂₂H₃₁NO₄Si 
• 934286-75-6 C₂₂H₃₁NO₄Si 

Relevant academic research and scientific papers

Bulky N-Heterocyclic-Carbene-Coordinated Palladium Catalysts for 1,2-Addition of Arylboron Compounds to Carbonyl Compounds

The synthesis of primary, secondary, and tertiary alcohols by the 1,2-addition of arylboronic acids or boronates to carbonyl compounds, including unactivated ketones, using novel bulky yet flexible N-heterocyclic carbene (NHC)-coordinated 2,6-di(pentan-3-yl)aniline (IPent)-based cyclometallated palladium complexes (CYPs) as catalysts is reported. The PhS-IPent-CYP-catalyzed reactions are efficient at low catalyst loadings (0.02–0.3 mol% Pd), and the exceptional catalytic activity for 1,2-addition is attributed to the steric bulk of the NHC ligand. These reactions can yield a wide range of functionalized benzylic alcohols that are difficult to synthesize by classical protocols using highly active organomagnesium or lithium reagents.

Palladium-catalyzed hydroxymethylation of aryl-and heteroarylboronic acids using aqueous formaldehyde

Cyclometallated NHC palladium complexes prepared from palladium(II) acetate [Pd(OAc)2] and unsymmetrical 1,3-diarylimidazolinium salts catalyzed the hydroxymethylation of (hetero)arylboronic acids using an excess amount of formalin to afford (hetero)arylm

Novel pyridinyl and pyrimidinylcarbazole sulfonamides as antiproliferative agents

A series of azaheterocyclic carbazole sulfonamides was synthesized and evaluated for antiproliferative activity. The most potent compounds N-(2,6-dimethoxypyridine-3-yl)-9-ethyl and 9-methylcarbazole-3-sulfonamide (13 and 14) gave significant cytotoxicity (IC50 = 122 and 101 nM). Compound 13 displayed submicromolar activities against seven human tumor cell lines. The SARs of this series of sulfonamides which includes the influence of azaheterocycle rings, sulfonamide linkage, and the carbazole ring are described.

NITROGENOUS CYCLIC KETONE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE

A novel compound represented by the formula (I): wherein rings A and B each represents an optionally substituted aromatic ring, or rings A and B may be bonded to each other through linking between bonds or substituents thereof to form a ring; ring C represents a nitrogenous saturated heterocycle optionally having one or more substituents besides the oxo (provided that 2,3-dioxopyrrolidine ring is excluded); R1 represents hydrogen, an optionally substituted hydrocarbon group, or an optionally substituted heterocyclic group; and-------- indicates a single bond or a double bond. It has high antagonistic activity against a tachykinin receptor, especially an SP receptor.